| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,007 |
20,298 |
$991K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,389 |
8,240 |
$594K |
| 87428 |
|
3,513 |
3,463 |
$199K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,587 |
2,546 |
$140K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,705 |
2,668 |
$71K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,901 |
3,802 |
$47K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
468 |
451 |
$30K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
717 |
699 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,943 |
966 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
266 |
265 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
405 |
399 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
379 |
367 |
$13K |
| 87634 |
|
176 |
173 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
112 |
110 |
$3K |
| 81025 |
|
321 |
317 |
$2K |
| 81003 |
|
970 |
950 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
177 |
170 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
59 |
58 |
$697.11 |